|
Jan 16
|
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
Jan 15
|
Why Summit Therapeutics Rocketed 584% in 2024
|
|
Jan 4
|
Prediction: These 3 Healthcare Stocks Will Soar in 2025
|
|
Jan 1
|
Why Is Summit Therapeutics Inc. (SMMT) Among the Best Multibagger Stocks to Buy Right Now?
|
|
Dec 29
|
3 Stocks That Could Be Monster Winners in 2025
|
|
Nov 14
|
Merck Spends Up To $3.3 Billion In An Insurance Policy Against Summit Therapeutics
|
|
Nov 10
|
TipRanks’ ‘Perfect 10’ Picks: 2 Top-Scoring Stocks for the Rest of 2024
|
|
Nov 8
|
2 Hot Biopharma Stocks to Buy and Hold for 5 Years
|
|
Oct 3
|
Summit Therapeutics Announces Completion of Enrollment in Its Phase III HARMONi Trial in 2L+ EGFRm NSCLC
|
|
Oct 3
|
Where Will Summit Therapeutics Be in 3 Years?
|
|
Oct 2
|
Has Summit Therapeutics Stock Already Peaked?
|
|
Sep 30
|
Is Summit Therapeutics Stock a Buy?
|
|
Sep 29
|
2 High-Potential Growth Stocks You Shouldn't Overlook
|
|
Sep 28
|
Better Rising Biotech: Viking Therapeutics vs. Summit Therapeutics
|
|
Sep 26
|
Is Summit Therapeutics Inc. (SMMT) the Best Performing Stock in 2024?
|
|
Sep 25
|
2 Stocks Up Over 700% in 2024 That Could Soar Even Further
|
|
Jul 29
|
Summit Therapeutics to Host Second Quarter 2024 Financial Results & Operational Progress Call on August 6, 2024
|
|
Jul 25
|
Summit Therapeutics and MD Anderson Announce Strategic Collaboration to Accelerate Development of Ivonescimab
|
|
May 2
|
Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2024 Earnings Call Transcript
|
|
May 2
|
Summit Therapeutics Inc (SMMT) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights ...
|